milrinone lactate injection VIAL How Supplied/Storage and Handling
HOW SUPPLIED
Milrinone Lactate Injection is supplied as 10 mL, 20 mL and 50 mL single-dose vials containing a sterile, clear, colorless to pale yellow solution. Each mL contains milrinone lactate equivalent to 1 mg milrinone.
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-0212-01 10 single-dose vials in a carton | 10 mg/10 mL (1 mg/mL) |
| NDC 0409-0212-02 10 single-dose vials in a carton | 20 mg/20 mL (1 mg/mL) |
| NDC 0409-0212-03 1 single-dose vial in a carton | 50 mg/50 mL (1 mg/mL) |
Discard unused portion after initial use. Store between 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Avoid freezing.
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing.
Manufactured by:
Gland Pharma Limited,
Hyderabad 500043, India
Manufactured for: 
Hospira Inc.
Lake Forest, IL 60045, USA
LAB-1255-2.0
Revised: 02/2021
Find milrinone lactate injection VIALÂ medical information:
Find milrinone lactate injection VIAL medical information:
milrinone lactate injection VIAL Quick Finder
Health Professional Information
How Supplied/Storage and Handling
HOW SUPPLIED
Milrinone Lactate Injection is supplied as 10 mL, 20 mL and 50 mL single-dose vials containing a sterile, clear, colorless to pale yellow solution. Each mL contains milrinone lactate equivalent to 1 mg milrinone.
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-0212-01 10 single-dose vials in a carton | 10 mg/10 mL (1 mg/mL) |
| NDC 0409-0212-02 10 single-dose vials in a carton | 20 mg/20 mL (1 mg/mL) |
| NDC 0409-0212-03 1 single-dose vial in a carton | 50 mg/50 mL (1 mg/mL) |
Discard unused portion after initial use. Store between 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Avoid freezing.
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing.
Manufactured by:
Gland Pharma Limited,
Hyderabad 500043, India
Manufactured for:
Hospira Inc.
Lake Forest, IL 60045, USA
LAB-1255-2.0
Revised: 02/2021
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.